MedPath

IPSEN BIOPHARMACEUTICALS, INC.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
https://www.dysport.com

Clinical Trials

6

Active:6
Completed:0

Trial Phases

1 Phases

Phase 1:6

Drug Approvals

5

FDA:5

Drug Approvals

Increlex

Approval Date
Mar 20, 2024
FDA

Onivyde

Approval Date
Feb 16, 2024
FDA

SOMATULINE DEPOT

Approval Date
Nov 2, 2023
FDA

Dysport

Approval Date
Sep 28, 2023
FDA

SOHONOS

Approval Date
Aug 24, 2023
FDA

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Phase 1
6 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.